Mesenchymal stem cells in cisplatin-induced acute renal failure

This study aims to test the feasibility and safety of systemic infusion of donor ex-vivo-expanded mesenchymal stem cells (MSCs) for kidney repair of kidney and to improve kidney function in patients with solid organ cancers who develop acute renal failure after chemotherapy with cisplatin.